Device Trial Radar · NCT04437862
A Study to Evaluate the Q Revascularization System for Neurointervention in Acute Ischemic Stroke
Last checked: Nov 20, 2026Latest source record: Aug 9, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
121
Actual
Start
Oct 27, 2020
Primary completion
Apr 21, 2023
Study completion Aug 2, 2023
Sponsor
- Lead sponsor
- MIVI Neuroscience, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 18, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Assess the safety and efficacy of the Q Revascularization System to remove thrombi and emboli from the neurovasculature in patients experiencing an acute ischemic stroke
Conditions
- Acute Stroke
- Cerebral Ischemia
Interventions
Q Revascularization SystemDevice
Q Revascularization System for mechanical thrombectomy
Primary outcomes
What the sponsor says the trial is designed to measure.
- Successful revascularization rateTime frame: Procedure end
1 more outcomes with a free account
Locations
8 sites in 2 countries. Site status is shown where the registry gives one.
University of South Florida
Tampa, Florida
7 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.